On November 4, 2025, Relay Therapeutics appointed Lonnel Coats and Habib Dable to its Board of Directors, expanding its membership from seven to nine. Each received options to purchase 207,931 shares at $6.86 each, vesting over three years.
AI Assistant
RELAY THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.